Showing results for "#Bharat Biotech"
"Safety is primary focus for all our vaccines": Covaxin-developer...
According to several UK media reports, AstraZeneca has made the admission in court documents in connection with a case that alleges that the vaccine,...
No major adverse events in 2 phases of Covaxin trials: Bharat Biotech
"The Phase III efficacy data will be available approximately at the end of Q1 in 2021, after which we will apply for regulatory approval for release...
India’s COVID vaccines in race to go global
Bharat Biotech is in discussions with more than 10 countries that have shown an interest in a potential COVID-19 vaccine it is developing with a...
Covaxin phase three trial to start next month
With the first two phases not throwing up any adverse effects, the phase three trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, is likely to start...
Bharat Biotech inks pact with WU's School of Medicine for COVID-19...
Bharat Biotech on Wednesday signed a licensing agreement with Washington University School of Medicine in St Louis, US for a novel "chimp-adenovirus",...
Seven Indian pharma players race to develop vaccine for COVID-19
At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive to check...
Bharat Biotech's COVID-19 vaccine clinical trials done on 375...
"India''s first indigenous COVID-19 vaccine Covaxin initiated phase-1 clinical trials across the country on 15th July 2020. This is a randomised,...
Covid vaccine: India to start human clinical trials in July
Leading vaccine maker Bharat Biotech on Monday announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in...
